New Portable, Secure, AI-Powered Speech Recognition to Help GPs Reduce Workloads
Augnito from Scribetech cuts workload and streamlines processes in general practice.
[London, 2 September 2021] – Clinical voice solutions specialist, Scribetech, has announced the launch of its new cloud-based voice AI product, Augnito.
Augnito is an evolution of Scribetech’s digital dictation and transcription services, which have been used in the NHS for 20 years. It has been launched in response to the need for GPs and practice staff to maximise their time and reduce contact with shared keyboards and equipment under increasing pressure as a result of the pandemic.
GPs provide an estimated 300 million patient consultations each year in the UK and each instance generates a new record in the patient’s history or an update to an existing one. This means GPs and secretaries are under increasing pressure to complete a significant amount of administration as quickly as possible.
Augnito is a portable, secure, cloud-based, AI-driven clinical speech recognition platform that offers a fast and efficient way to capture live clinical data on any device, Windows, Mac, or smartphone, with 99% accuracy. It turns medical information into clinical documentation by automatically transcribing medical records, referrals, or patient letters at the cursor and point of dictation. Augnito supports many medical speciality language models in addition to recognising all regional and international accents and dialects. With its easy to integrate API and software development kit, Augnito can be added seamlessly to existing electronic patient record systems and is proven to save GPs up to an hour of admin per day.
Shiraz Austin, Co-Founder and Managing Director of Scribetech, said: “Voice technology has a critical role to play in our healthcare system. The pandemic has highlighted the fact that clinicians are time poor and there is a clear need for more efficient solutions to help them prioritise patient care. Augnito is designed to significantly reduce the workload of GPs and support staff allowing them to focus on more important tasks.”
Speech is three times faster than typing and with Augnito, GPs can navigate clinical systems with just their voice. This enables them to maximise the speed at which medical records, referrals and patient letters are generated.
Shiraz went on to say: “Scribetech developed Augnito with the aim of delivering timely and accurately transcribed medical documents. With the input of doctors and AI scientists we’ve been able to a build a product suite we believe is the next generation of voice powered technology. It’s making a huge difference to medical institutions across the globe.”
About Scribetech and Augnito
Scribetech (UK) Ltd is a clinical voice solutions innovator, fusing 20 years of transcription and digital dictation services to the NHS, speech-to-text and clinical coding solutions for the healthcare sector, and its own speech recognition engine and advanced voice AI technology.
For two decades, Scribetech has consistently delivered accurate, efficient, cost-effective services and technology to support clinical transcription. Now, the team has combined this experience with 8 years of research and development, including 2 million hours of input from strategists, scientists, analysts, engineers and clinicians. The result is Augnito: a secure, cloud-based and AI-driven clinical speech recognition product suite.
Augnito offers fast, easy ways to capture live clinical data on any device with 99% accuracy, support for multiple medical specialties, and no need for voice profile training. It brings seamless speech recognition to daily workflows and third-party clinical systems, turning medical information into clinical documentation and making healthcare intelligence securely accessible, everywhere.
Scribetech is fully certified for the Data Security and Protection Toolkit and Cyber Essentials+. Its security, quality control and management processes are UKAS certified for ISO 9001, ISO 14001 and ISO 27001 for information security management.